HSBC Holdings
MDCO

HSBC Holdings’s Medicines Co MDCO Stock Holding History

HSBC Holdings’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,730
Closed -$741K – 3177
2019
Q4 		$741K Buy
8,730
+1,025
+13% +$68.4K ﹤0.01% 2012
2019
Q3 		$385K Buy
+7,705
New +$307K ﹤0.01% 2474
2017
Q3 		– Sell
-10,495
Closed -$407K – 2348
2017
Q2 		$407K Buy
10,495
+3,798
+57% +$169K ﹤0.01% 1756
2017
Q1 		$327K Sell
6,697
-20,052
-75% -$915K ﹤0.01% 1766
2016
Q4 		$910K Buy
26,749
+11,344
+74% +$402K ﹤0.01% 1462
2016
Q3 		$588K Buy
+15,405
New +$581K ﹤0.01% 1517
2015
Q4 		– Sell
-6,842
Closed -$260K – 2288
2015
Q3 		$260K Sell
6,842
-6,167
-47% -$216K ﹤0.01% 1686
2015
Q2 		$373K Buy
13,009
+2,975
+30% +$82.9K ﹤0.01% 1522
2015
Q1 		$283K Buy
10,034
+75
+0.8% +$2.11K ﹤0.01% 1768
2014
Q4 		$277K Buy
+9,959
New +$247K ﹤0.01% 1626
2013
Q3 		– Sell
-7,000
Closed -$215K – 1815
2013
Q2 		$215K Buy
+7,000
New +$234K ﹤0.01% 1419

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

HSBC Holdings's MDCO Position: Q1 2020 in Review

HSBC Holdings sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 8,730 shares — an estimated $741K sold.

HSBC Holdings first reported a position in MDCO in Q2 2013 and held it in 11 quarters. The position peaked at $910K in Q4 2016. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • HSBC Holdings reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • HSBC Holdings sold 8,730 Medicines Co shares in Q1 2020, an estimated $741K.
  • HSBC Holdings first reported a position in Medicines Co in Q2 2013 and held it in 11 quarters.
  • HSBC Holdings's Medicines Co position peaked at $910K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on HSBC Holdings's 13F filing for Q1 2020, filed 15 May 2020.